L3 Pleasure and addiction Flashcards
Name 4 characteristics of DSM-V, substance use disorder
Withdrawal Tolerance Craving Increased use Desire/need to reduce intake (repeated quit attempts Lot of time spent pursuing drug. Social, occupational activities affected. Neglect major roles Legal problems Hazardous use
What NT pathway does cocaine act on?
Dopamine
What is a reward defined as in the context of addiction?
Subjective pleasure
Why are rewards important?
Fundamental for motivation and goal-seeking behaviour.
Basis for instinctive drives: hunger, thirst, sex.
Substrate of more complex states: desire, motivation, ambition, goals.
What is Bozarth and Wise study in 1985 and what did they find?
Gave rats unlimited access to cocaine. Increased dose, stopped eating, grooming,
sleeping, etc. 90% fatalities by day 25.
What pathway is also known as the brain’s pleasure centre?
dopamine pathway
What are the 2 main dopamine pathways in the brain?
Substantia nigra – black substance. Cells are full of dopamine and the region looks darker. In PD this part of the brain dies off.
Ventral tegmental area – this is the one involved in addication. Early work in rats was stimulating this pathway.
In what disease does the Substantia nigra die off?
Parkinson’s Disease
Which dopamine pathway is involved in addiction?
Mesolimbic Dopamine Pathway
Does nicotine increase dopamine release in the Ventral tegmental area?
No, it increases dopamine release in the Nucleus Accumbens (NA)
Name the 2 key components of the Mesolimbic Dopamine Pathway
Ventral tegmental area Nucleus Accumbens (NA)
What do dopamine pathway blockers decrease?
Motivation/desire for reward.
What disease are neuroleptics commonly used in ?
schizophrenia
What is the anhedonia hypothesis?
Brain DA mediates pleasure.
The DA system is where ‘sensory inputs are translated into the hedonic messages we experience as pleasure, euphoria or ‘yumminess’’
Pleasure (& pain) motivates drug use.
Name a major criticism of the anhedonia hypothesis
Doesn’t account for cravings/relapse after a period of not using the drug.